Merck Settles Fosamax Jaw-Injury Claims For $28M

Merck Settles Fosamax Jaw-Injury Claims For $28M

Resolving long-running multidistrict litigation in New York, Merck & Co. Inc. agreed Monday to pay $27.7 million to settle hundreds of lawsuits claiming its bone drug Fosamax caused a condition known as osteonecrosis of the jaw. ...read more

  • Tags: